Novel Coronavirus
Coronavirus disease is a newly discovered coronavirus-infectious disease. Most people with COVID-19 suffer from mild to moderate symptoms and are recovering without special treatment. The COVID 19 virus is mainly transmitted via droplets generated by the coughing, sneezing, or exhaling of an infected person. They are too heavy to hang in the air and fall quickly on floors or surfaces.
- Most common symptoms
- Less common symptoms
- Etymology
- Microbiology
- Genome
- Infection in humans
- Prevention and treatment
Related Conference of Novel Coronavirus
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergy and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
Novel Coronavirus Conference Speakers
Recommended Sessions
- Antimicrobial Agents
- Bioterrorism and Preparedness
- Case Studies of Various Emerging Diseases
- Current Research and Advancements
- Dermatological Infectious Diseases
- Dynamics of infectious diseases
- Ecology of infectious diseases
- Evolution and natural selection in infectious diseases
- Foodborne and Waterborne Illnesses
- Gastrointestinal Infections
- Genomics in infectious disease surveillance and control
- Host behaviour and infectious diseases
- Infectious diseases in a changing environment and climate
- Infectious Diseases in Children
- Maternal Infectious Diseases
- Molecular Diagnostics and Epidemiology
- Nosocomial Infections
- Novel Coronavirus
- Optimization of infectious disease surveillance and control
- Pharmacology and Infectious Diseases
- Phylodynamics and infectious diseases
- Plant Pathology and Disease Control
- Statistical methods for infectious disease data
- Vector-borne diseases
- Zoonotic Diseases
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)